profit from every $100 of sales.
$0$100
Drugs Made In America Acquisition Corp. Rights
$0.13+17.59% today
-43.2% in 1 year
1-year low $0.041-year high $0.22
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $37.49 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Drugs Made In America Acquisition Corp. Rights vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Drugs Made In America Acquisition Corp. Rights | 37.5× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Unusual Machines | No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Armada Acquisition Corp. II | 336.8× · No profit yet |
AI analysis
An AI analyst reads Drugs Made In America Acquisition Corp. Rights's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 37.5×
- –
- 0.00
- 1.0×
- 0.0×
- –
- –
- -20.3%
- 2.7%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -1.2%
- -56.0%
- 2.6%
- 2.5%
- -1.2%
- –
Growth
- –
- –
- −182,675.3%
- –
- +145.1%
Financial health
- -0.0×
- 0.00
- 0.0%
- –
- 0.03
- 0.03
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 7%of 827
Bottom 6%of 709
Bottom 12%of 876
Bottom 6%of 926
News
Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision lossMarketWatch · Nov 9, 2026Generate, Zealand in collaboration to develop drugs for obesity, metabolic diseasesSeeking Alpha · Oct 13, 2026As GLP-1 Drugs Change How People Eat, Drugmakers Collect and Snack Makers Feel the SqueezeYahoo Finance · Oct 11, 2026Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1sCNBC · Oct 2, 2026Beyond GLP-1 injectables, who wins the next phase for obesity drugs?Seeking Alpha · Sep 25, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
20No pass
Benjamin Graham
39No pass
Philip Fisher
29No pass
Peter Lynch
60Pass
Joel Greenblatt
6No pass
Charlie Munger
23No pass
Terry Smith
23No pass
Questions about Drugs Made In America Acquisition Corp. Rights
Is Drugs Made In America Acquisition Corp. Rights a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Drugs Made In America Acquisition Corp. Rights AI analysis
What does Drugs Made In America Acquisition Corp. Rights do?
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. It is in Shell Companies.
Does Drugs Made In America Acquisition Corp. Rights pay a dividend?
No. Drugs Made In America Acquisition Corp. Rights does not pay a dividend at the moment.
Is Drugs Made In America Acquisition Corp. Rights stock halal?
Questionable. Drugs Made In America Acquisition Corp. Rights sits in a grey zone: scholars disagree about its industry. How we check
How has Drugs Made In America Acquisition Corp. Rights stock done over the past year?
Down 43.2% over the past twelve months, to $0.13. It traded between $0.04 and $0.22 and is 43.2% below its high.
Who are Drugs Made In America Acquisition Corp. Rights's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Unusual Machines, Bain Capital GSS Investment Cor and Armada Acquisition Corp. II. The peers table on this page compares their profit, growth and price with Drugs Made In America Acquisition Corp. Rights's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.